Metal-based immunogenic cell death inducers for cancer immunotherapy

Area of Science:

• Oncology
• Immunology
• Materials Science

Background:

• Immunogenic cell death (ICD) is crucial for activating anti-tumor immunity.
• Metal complexes show promise as effective ICD inducers.
• Significant research is ongoing to discover and validate novel ICD inducers.

Purpose of the Study:

• To comprehensively review current metal-based ICD inducers.
• To elucidate the molecular mechanisms of ICD initiation and immune response activation by metal complexes.
• To discuss considerations for validating ICD and future directions in metal-based cancer immunotherapy.

Main Methods:

• Literature review of metal-based ICD inducers.
• Analysis of molecular mechanisms underlying ICD.
• Discussion of in vitro and in vivo validation strategies for ICD.
• Exploration of future development and applications of metal complexes in cancer treatment.

Main Results:

• Several metal complexes have been validated as ICD inducers.
• These complexes trigger ICD and subsequent anti-tumor immune responses.
• Understanding their mechanisms is key to optimizing their therapeutic potential.

Conclusions:

• Metal complexes represent a promising class of compounds for inducing ICD.
• Further research into their mechanisms and validation is essential for advancing cancer immunotherapy.
• Development of enhanced metal-based ICD inducers holds significant potential for potentiating anti-tumor immunity.